American Association for Cancer Research (AACR) 2024: TEAD1/4 inhibitors exhibit deeper biological impact and broader activity compared to TEAD1-only inhibitors in both monotherapy and combination without additional kidney toxicity
Apr 12, 2024
View PresentationAmerican Association for Cancer Research (AACR) 2024: VGLL4 is the target of the 3p25 homozygous deletion and presents a novel therapeutic vulnerability for TEAD1/4 but not TEAD1 inhibitors
Apr 12, 2024
View PresentationAmerican Association for Cancer Research (AACR) 2023: A next generation TEAD inhibitor with refined isoform specificity for superior safety & efficacy
Apr 17, 2023
View PresentationOppenheimer 33rd Annual Healthcare Conference
March 15, 2023
Read MoreAmerican Association for Cancer Research (AACR) Special Conference: Targeting RAS
Mar 7, 2023
View Presentation34th EORTC-NCI-AACR Symposium
Oct 27, 2022
View PresentationSporos BioDiscovery to Present Preclinical Findings on SPR1, a Next-Generation TEAD Inhibitor, at the American Association for Cancer Research (AACR) Annual Meeting 2024
Mar 6, 2024
Read MoreSporos BioDiscovery Presents Preclinical Data on Next-Generation TEAD Inhibitor, SPR1-0117, at the American Association for Cancer Research (AACR) Annual Meeting 2023
Apr 17, 2023
Read MoreSporos BioDiscovery to Present Preclinical Findings on SPR1, a Next-Generation TEAD Inhibitor, at the American Association for Cancer Research (AACR) Annual Meeting 2023
Mar 15, 2023
Read MoreSporos BioDiscovery to Present at the Oppenheimer 33rd Annual Healthcare Conference
Mar 9, 2023
Read MoreSporos BioDiscovery Presents Preclinical Data on Differentiated TEAD Inhibitor Program, SPR1, at the 34th EORTC-NCI-AACR Symposium
Oct 27, 2022
Read MoreSporos Bioventures Announces Formation of Strategic Advisory Board
Jan 11, 2022
Read MoreSporos Bioventures Appoints Dr. Rachel Humphrey to Board of Directors
Jan 4, 2022
Read MoreSporos Bioventures Appoints Amit Rakhit, M.D. as Chief Executive Officer
Sep 19, 2021
Read MoreSporos Launches with $38.1 Million Series A Financing
May 6, 2021
Read More